Literature DB >> 20705807

NCCN Task Force Report: Specialty Pharmacy.

Rowena N Schwartz, Kirby J Eng, Deborah A Frieze, Tracy K Gosselin, Niesha Griffith, Amy Hatfield Seung, Jennifer M Hinkel, Philip E Johnson, Shirley A Johnson, Edward C Li, Audrea Hotsko Szabatura, Michael K Wong.   

Abstract

The use of specialty pharmacies is expanding in oncology pharmacy practice. Specialty pharmacies provide a channel for distributing drugs that, from the payor perspective, creates economies of scale and streamlines the delivery of expensive drugs. Proposed goals of specialty pharmacy include optimization of pharmaceutical care outcomes through ensuring appropriate medication use and maximizing adherence, and optimization of economic outcomes through avoiding unwarranted drug expenditure. In oncology practice, specialty pharmacies have become a distribution channel for various agents. The use of a specialty pharmacy, and the addition of the pharmacist from the specialty pharmacy to the health care team, may not only provide benefits for care but also present challenges in oncology practice. The NCCN Specialty Pharmacy Task Force met to identify and examine the impact of specialty pharmacy practice on the care of people with cancer, and to provide recommendations regarding issues discussed. This report provides recommendations within the following categories: education and training of specialty pharmacy practitioners who care for individuals with cancer, coordination of care, and patient safety. Areas for further evaluation are also identified.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20705807     DOI: 10.6004/jnccn.2010.0127

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  11 in total

1.  Impact of clinical oral chemotherapy program on wastage and hospitalizations.

Authors:  Nikhil Khandelwal; Ian Duncan; Tamim Ahmed; Elan Rubinstein; Cheryl Pegus
Journal:  J Oncol Pract       Date:  2011-05       Impact factor: 3.840

Review 2.  Adherence in pediatric kidney transplant recipients: solutions for the system.

Authors:  Elizabeth A Steinberg; Mary Moss; Cindy L Buchanan; Jens Goebel
Journal:  Pediatr Nephrol       Date:  2017-03-27       Impact factor: 3.714

3.  Specialty Pharmacy Services: Preparing for a New Era in Health-System Pharmacy.

Authors:  Blake Shay; Les Louden; Bonnie Kirschenbaum
Journal:  Hosp Pharm       Date:  2015-10-14

Review 4.  Oral Chemotherapy in Patients with Hematological Malignancies-Care Process, Pharmacoeconomic and Policy Implications.

Authors:  Jeffrey Betcher; Elizabeth Dow; Nandita Khera
Journal:  Curr Hematol Malig Rep       Date:  2016-08       Impact factor: 3.952

5.  The relationship between patient activation, confidence to self-manage side effects, and adherence to oral oncolytics: a pilot study with Michigan oncology practices.

Authors:  Teresa M Salgado; Emily Mackler; Jane A Severson; Jamie Lindsay; Peter Batra; Laura Petersen; Karen B Farris
Journal:  Support Care Cancer       Date:  2017-01-20       Impact factor: 3.603

6.  Are community-based pharmacists underused in the care of persons living with HIV? A need for structural and policy changes.

Authors:  Jennifer Kibicho; Steven D Pinkerton; Jill Owczarzak; Lucy Mkandawire-Valhmu; Peninnah M Kako
Journal:  J Am Pharm Assoc (2003)       Date:  2015 Jan-Feb

7.  Pharmaceutical care for patients with breast and ovarian cancer.

Authors:  Andrea Liekweg; Martina Westfeld; Michael Braun; Oliver Zivanovic; Tania Schink; Walther Kuhn; Ulrich Jaehde
Journal:  Support Care Cancer       Date:  2012-11       Impact factor: 3.603

Review 8.  A review of approaches for the management of specialty pharmaceuticals in the United States.

Authors:  Bijal Nitin Patel; Patricia R Audet
Journal:  Pharmacoeconomics       Date:  2014-11       Impact factor: 4.981

Review 9.  BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.

Authors:  Sandra Cuellar; Michael Vozniak; Jill Rhodes; Nicholas Forcello; Daniel Olszta
Journal:  J Oncol Pharm Pract       Date:  2017-06-04       Impact factor: 1.809

10.  2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice Standard.

Authors:  Emily Mackler; Eve M Segal; Benyam Muluneh; Kate Jeffers; Jenna Carmichael
Journal:  J Oncol Pract       Date:  2019-03-12       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.